These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

356 related items for PubMed ID: 28215694

  • 1. Comparisons of the humoral and cellular immunity induced by live A16R attenuated spore and AVA-like anthrax vaccine in mice.
    Lv J, Zhang YY, Lu X, Zhang H, Wei L, Gao J, Hu B, Hu WW, Hu DZ, Jia N, Feng X.
    Biologicals; 2017 Mar; 46():130-138. PubMed ID: 28215694
    [Abstract] [Full Text] [Related]

  • 2. Immunological dynamics in response to two anthrax vaccines in mice.
    Lü J, He R, Dong M, Zhang L, Wang X.
    Sci China C Life Sci; 2008 Oct; 51(10):872-8. PubMed ID: 18815750
    [Abstract] [Full Text] [Related]

  • 3. The role of antibodies to Bacillus anthracis and anthrax toxin components in inhibiting the early stages of infection by anthrax spores.
    Welkos S, Little S, Friedlander A, Fritz D, Fellows P.
    Microbiology (Reading); 2001 Jun; 147(Pt 6):1677-1685. PubMed ID: 11390699
    [Abstract] [Full Text] [Related]

  • 4. A Bivalent Protein r-PAbxpB Comprising PA Domain IV and Exosporium Protein BxpB Confers Protection Against B. anthracis Spores and Toxin.
    Majumder S, Das S, Somani VK, Makam SS, Kingston JJ, Bhatnagar R.
    Front Immunol; 2019 Jun; 10():498. PubMed ID: 30941133
    [Abstract] [Full Text] [Related]

  • 5. A novel live attenuated anthrax spore vaccine based on an acapsular Bacillus anthracis Sterne strain with mutations in the htrA, lef and cya genes.
    Chitlaru T, Israeli M, Rotem S, Elia U, Bar-Haim E, Ehrlich S, Cohen O, Shafferman A.
    Vaccine; 2017 Oct 20; 35(44):6030-6040. PubMed ID: 28342664
    [Abstract] [Full Text] [Related]

  • 6. Comparative analysis of the immunologic response induced by the Sterne 34F2 live spore Bacillus anthracis vaccine in a ruminant model.
    Ndumnego OC, Köhler SM, Crafford J, van Heerden H, Beyer W.
    Vet Immunol Immunopathol; 2016 Oct 01; 178():14-21. PubMed ID: 27496738
    [Abstract] [Full Text] [Related]

  • 7. Trimethyl Chitosan Nanoparticles Encapsulated Protective Antigen Protects the Mice Against Anthrax.
    Malik A, Gupta M, Mani R, Gogoi H, Bhatnagar R.
    Front Immunol; 2018 Oct 01; 9():562. PubMed ID: 29616046
    [Abstract] [Full Text] [Related]

  • 8. Mucosal immunization with a novel nanoemulsion-based recombinant anthrax protective antigen vaccine protects against Bacillus anthracis spore challenge.
    Bielinska AU, Janczak KW, Landers JJ, Makidon P, Sower LE, Peterson JW, Baker JR.
    Infect Immun; 2007 Aug 01; 75(8):4020-9. PubMed ID: 17502384
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Cutting Edge: IFN-gamma-producing CD4 T lymphocytes mediate spore-induced immunity to capsulated Bacillus anthracis.
    Glomski IJ, Corre JP, Mock M, Goossens PL.
    J Immunol; 2007 Mar 01; 178(5):2646-50. PubMed ID: 17312104
    [Abstract] [Full Text] [Related]

  • 12. A cationic lipid-formulated plasmid DNA vaccine confers sustained antibody-mediated protection against aerosolized anthrax spores.
    Hermanson G, Whitlow V, Parker S, Tonsky K, Rusalov D, Ferrari M, Lalor P, Komai M, Mere R, Bell M, Brenneman K, Mateczun A, Evans T, Kaslow D, Galloway D, Hobart P.
    Proc Natl Acad Sci U S A; 2004 Sep 14; 101(37):13601-6. PubMed ID: 15342913
    [Abstract] [Full Text] [Related]

  • 13. A single-dose PLGA encapsulated protective antigen domain 4 nanoformulation protects mice against Bacillus anthracis spore challenge.
    Manish M, Rahi A, Kaur M, Bhatnagar R, Singh S.
    PLoS One; 2013 Sep 14; 8(4):e61885. PubMed ID: 23637922
    [Abstract] [Full Text] [Related]

  • 14. Efficacy of a vaccine based on protective antigen and killed spores against experimental inhalational anthrax.
    Gauthier YP, Tournier JN, Paucod JC, Corre JP, Mock M, Goossens PL, Vidal DR.
    Infect Immun; 2009 Mar 14; 77(3):1197-207. PubMed ID: 19114543
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A three-dose intramuscular injection schedule of anthrax vaccine adsorbed generates sustained humoral and cellular immune responses to protective antigen and provides long-term protection against inhalation anthrax in rhesus macaques.
    Quinn CP, Sabourin CL, Niemuth NA, Li H, Semenova VA, Rudge TL, Mayfield HJ, Schiffer J, Mittler RS, Ibegbu CC, Wrammert J, Ahmed R, Brys AM, Hunt RE, Levesque D, Estep JE, Barnewall RE, Robinson DM, Plikaytis BD, Marano N, AVRP Laboratory Working Group.
    Clin Vaccine Immunol; 2012 Nov 14; 19(11):1730-45. PubMed ID: 22933399
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Enhanced early innate and T cell-mediated responses in subjects immunized with Anthrax Vaccine Adsorbed Plus CPG 7909 (AV7909).
    Minang JT, Inglefield JR, Harris AM, Lathey JL, Alleva DG, Sweeney DL, Hopkins RJ, Lacy MJ, Bernton EW.
    Vaccine; 2014 Nov 28; 32(50):6847-54. PubMed ID: 24530403
    [Abstract] [Full Text] [Related]

  • 20. Immunopotentiation of Different Adjuvants on Humoral and Cellular Immune Responses Induced by HA1-2 Subunit Vaccines of H7N9 Influenza in Mice.
    Song L, Xiong D, Hu M, Kang X, Pan Z, Jiao X.
    PLoS One; 2016 Nov 28; 11(3):e0150678. PubMed ID: 26930068
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.